American Oncology Network Statistics
Total Valuation
American Oncology Network has a market cap or net worth of 66.63 million. The enterprise value is 256.18 million.
| Market Cap | 66.63M |
| Enterprise Value | 256.18M |
Important Dates
The next estimated earnings date is Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
American Oncology Network has 21.42 million shares outstanding.
| Shares Outstanding | 21.42M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +392.70% |
| Owned by Insiders (%) | 41.80% |
| Owned by Institutions (%) | 0.11% |
| Float | 12.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.02 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -57.08 |
| EV / Sales | 0.18 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -14.08 |
Financial Position
The company has a current ratio of 1.32, with a Debt / Equity ratio of 2.80.
| Current Ratio | 1.32 |
| Quick Ratio | 1.04 |
| Debt / Equity | 2.80 |
| Debt / EBITDA | n/a |
| Debt / FCF | -8.29 |
| Interest Coverage | -5.75 |
Financial Efficiency
Return on equity (ROE) is -65.10% and return on invested capital (ROIC) is -11.44%.
| Return on Equity (ROE) | -65.10% |
| Return on Assets (ROA) | -6.11% |
| Return on Capital (ROIC) | -11.44% |
| Revenue Per Employee | 956,595 |
| Profits Per Employee | -2,943 |
| Employee Count | 1,525 |
| Asset Turnover | 3.52 |
| Inventory Turnover | 28.67 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.17% in the last 52 weeks. The beta is 0.34, so American Oncology Network's price volatility has been lower than the market average.
| Beta (5Y) | 0.34 |
| 52-Week Price Change | -48.17% |
| 50-Day Moving Average | 3.48 |
| 200-Day Moving Average | 3.79 |
| Relative Strength Index (RSI) | 42.98 |
| Average Volume (20 Days) | 3,885 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.46 |
Income Statement
In the last 12 months, American Oncology Network had revenue of 1.46 billion and -4.49 million in losses. Loss per share was -2.46.
| Revenue | 1.46B |
| Gross Profit | 80.33M |
| Operating Income | -40.48M |
| Pretax Income | -49.61M |
| Net Income | -4.49M |
| EBITDA | -31.45M |
| EBIT | -40.48M |
| Loss Per Share | -2.46 |
Balance Sheet
The company has 55.21 million in cash and 150.93 million in debt, giving a net cash position of -95.72 million or -4.47 per share.
| Cash & Cash Equivalents | 55.21M |
| Total Debt | 150.93M |
| Net Cash | -95.72M |
| Net Cash Per Share | -4.47 |
| Equity (Book Value) | 53.85M |
| Book Value Per Share | -2.96 |
| Working Capital | 74.71M |
Cash Flow
In the last 12 months, operating cash flow was -4.64 million and capital expenditures -13.56 million, giving a free cash flow of -18.20 million.
| Operating Cash Flow | -4.64M |
| Capital Expenditures | -13.56M |
| Free Cash Flow | -18.20M |
| FCF Per Share | -0.85 |
Margins
Gross margin is 5.51%, with operating and profit margins of -2.77% and 0.13%.
| Gross Margin | 5.51% |
| Operating Margin | -2.77% |
| Pretax Margin | -3.40% |
| Profit Margin | 0.13% |
| EBITDA Margin | -2.16% |
| EBIT Margin | -2.77% |
| FCF Margin | -1.25% |
Dividends & Yields
American Oncology Network does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 71.41% |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -79.00% |
| FCF Yield | -27.31% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
American Oncology Network has an Altman Z-Score of 3.14.
| Altman Z-Score | 3.14 |
| Piotroski F-Score | n/a |